Grantee News
August 14, 2020
A team has developed a class of light-switchable, highly adaptable molecular tools with new capabilities to control cellular activities. The antibody-like proteins, called OptoBinders, have potential applications including protein purification, the improved production of biofuels, and new types of targeted cancer therapies. Read more from Princeton Chemical and Biological Engineering News.